Doctronic Secures $40M Series B, Expands AI-Driven Medical Practice Across US

March 24, 2026
Doctronic Secures $40M Series B, Expands AI-Driven Medical Practice Across US
  • Doctronic, the first AI-enabled medical practice authorized to operate in the United States, announced a $40 million Series B led by Abstract and Lightspeed Venture Partners, bringing total funding to over $65 million as it scales under a year.

  • The funding underscores strong investor confidence in AI-driven medical administration and the company’s push to become the digital front door for care.

  • Doctronic is pursuing regulatory discussions beyond Utah and has established partnerships with major health systems, third-party administrators, and self-insured employers to broaden its AI-prescribing capabilities.

  • The company emphasizes autonomous AI that performs dozens of safety checks per prescription renewal, achieving a 99.2% treatment alignment rate, with physicians available for complex cases or video visits for a copay.

  • Leadership stresses durable consumer scale, real clinical workflow integration, and a safety- and outcomes-focused model, positioning Doctronic as infrastructure and a digital front door for care.

  • Doctronic now serves health systems, payers, and employers through cobranded partnerships while maintaining a direct-to-consumer platform used by millions nationwide.

  • The piece is presented as sponsor-filled tech/news content, which may influence depth and sourcing of the narrative.

  • The platform runs its own clinical practice licensed in all 50 states, is HIPAA-compliant, and offers 24/7 access with seamless integration to patient records, medication history, and drug interaction data through established health information networks.

  • In December 2025, Doctronic became the first AI-native platform to autonomously renew prescriptions within Utah’s AI Learning Lab regulatory sandbox, signaling regulatory validation of its clinical rigor.

  • Proceeds will fund hiring and technology scaling, with plans to roll out platform versions with digital health partners, health systems, and payers.

  • The round and pilots point to broader industry interest in automating routine pharmaceutical processes to boost efficiency and ease clinician workload.

  • Doctronic uses a collective intelligence architecture with specialized AI agents under physician oversight and offers unique AI medical malpractice insurance for autonomous AI practice.

Summary based on 3 sources


Get a daily email with more Tech stories

More Stories